Galectin Therapeutics (GALT) Net Income Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.99% |
| Dec 31, 2025 | 7.63% |
| Sep 30, 2025 | -0.12% |
| Jun 30, 2025 | -1.00% |
| Mar 31, 2025 | -21.99% |
| Dec 31, 2024 | -22.32% |
| Sep 30, 2024 | -30.33% |
| Jun 30, 2024 | -33.01% |
| Mar 31, 2024 | -34.92% |
| Dec 31, 2023 | -27.64% |
| Sep 30, 2023 | -29.28% |
| Jun 30, 2023 | -20.12% |
| Mar 31, 2023 | -20.37% |
| Dec 31, 2022 | -35.71% |
| Sep 30, 2022 | -13.69% |
| Jun 30, 2022 | -17.01% |
| Mar 31, 2022 | -15.53% |
| Dec 31, 2021 | -10.89% |
| Sep 30, 2021 | -12.76% |
| Jun 30, 2021 | -8.44% |
| Mar 31, 2021 | 1.40% |
| Dec 31, 2020 | -10.95% |
| Sep 30, 2020 | -0.19% |
| Jun 30, 2020 | -5.66% |
| Mar 31, 2020 | 5.92% |
| Dec 31, 2019 | -6.66% |
| Sep 30, 2019 | 4.28% |
| Jun 30, 2019 | 2.27% |
| Mar 31, 2019 | 13.27% |
| Dec 31, 2018 | -1.73% |
| Sep 30, 2018 | 4.92% |
| Jun 30, 2018 | -8.58% |
| Mar 31, 2018 | -5.86% |
| Dec 31, 2017 | 0.05% |
| Sep 30, 2017 | -8.82% |
| Jun 30, 2017 | -11.13% |
| Mar 31, 2017 | -20.42% |
| Dec 31, 2016 | -6.39% |
| Sep 30, 2016 | -17.42% |
| Jun 30, 2016 | -13.06% |
| Mar 31, 2016 | -27.63% |
| Dec 31, 2015 | -29.41% |
| Sep 30, 2015 | -37.24% |
| Jun 30, 2015 | -28.04% |